Sub-Total: $0.00
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Complimentary
Related products
-
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more -
New Paradigms in the Treatment and Management of Age-related Macular Degeneration (AMD)
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more
